TreeWAS – Variant ID: rs16827293

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H20 Iridocyclitis	0.110	0.890	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.107	0.893	0.000
H16 Keratitis	0.102	0.898	0.000
H20.0 Acute and subacute iridocyclitis	0.101	0.899	0.000
H20.9 Iridocyclitis, unspecified	0.100	0.900	0.000
H21 Other disorders of iris and ciliary body	0.099	0.901	0.000
H16.0 Corneal ulcer	0.096	0.904	0.000
H20.8 Other iridocyclitis	0.095	0.905	0.000
H20.1 Chronic iridocyclitis	0.094	0.906	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.089	0.911	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.087	0.913	0.000
H21.8 Other specified disorders of iris and ciliary body	0.084	0.915	0.000
H16.9 Keratitis, unspecified	0.082	0.918	0.000
H21.0 Hyphaema	0.081	0.919	0.000
H20.2 Lens-induced iridocyclitis	0.079	0.921	0.000
H16.2 Keratoconjunctivitis	0.079	0.921	0.000
H21.2 Degeneration of iris and ciliary body	0.078	0.922	0.000
H15 Disorders of sclera	0.077	0.923	0.000
H18 Other disorders of cornea	0.076	0.924	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.075	0.925	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.075	0.925	0.000
H16.8 Other keratitis	0.073	0.926	0.000
H16.4 Corneal neovascularisation	0.073	0.926	0.000
H16.3 Interstitial and deep keratitis	0.073	0.926	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.073	0.926	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.072	0.928	0.000
H21.4 Pupillary membranes	0.071	0.929	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.071	0.929	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.071	0.929	0.000
H17 Corneal scars and opacities	0.070	0.930	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.070	0.930	0.000
H18.5 Hereditary corneal dystrophies	0.065	0.935	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.064	0.936	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.064	0.936	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.064	0.936	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.064	0.936	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.062	0.937	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.062	0.937	0.000
H18.9 Disorder of cornea, unspecified	0.061	0.939	0.000
H18.0 Corneal pigmentations and deposits	0.059	0.941	0.000
H17.8 Other corneal scars and opacities	0.056	0.944	0.000
H15.9 Disorder of sclera, unspecified	0.055	0.944	0.000
H15.8 Other disorders of sclera	0.055	0.944	0.000
H15.1 Episcleritis	0.055	0.944	0.000
H15.0 Scleritis	0.055	0.944	0.000
H18.7 Other corneal deformities	0.055	0.945	0.000
H18.3 Changes in corneal membranes	0.055	0.945	0.000
H18.2 Other corneal oedema	0.053	0.947	0.000
H17.1 Other central corneal opacity	0.050	0.950	0.000
H17.0 Adherent leukoma	0.050	0.950	0.000
H18.8 Other specified disorders of cornea	0.049	0.951	0.000
H18.1 Bullous keratopathy	0.048	0.952	0.000
H18.4 Corneal degeneration	0.047	0.952	0.000
H18.6 Keratoconus	0.043	0.957	0.000
H17.9 Corneal scar and opacity, unspecified	0.033	0.967	0.001
Z36 Antenatal screening	0.029	0.971	0.000
Z36.8 Other antenatal screening	0.029	0.971	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.029	0.971	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.026	0.974	0.000
Z36.9 Antenatal screening, unspecified	0.024	0.976	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.023	0.977	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.023	0.977	0.000
C85.1 B-cell lymphoma, unspecified	0.022	0.978	0.000
Z36.5 Antenatal screening for isoimmunisation	0.021	0.979	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.020	0.980	0.000
N41.1 Chronic prostatitis	0.000	0.982	0.018
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.015	0.985	0.000
C81 Hodgkin's disease	0.015	0.985	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.015	0.985	0.000
C81.9 Hodgkin's disease, unspecified	0.014	0.986	0.000
C81.0 Lymphocytic predominance	0.013	0.987	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.013	0.987	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.013	0.987	0.000
C91 Lymphoid leukaemia	0.012	0.988	0.000
C81.7 Other Hodgkin's disease	0.012	0.988	0.000
C92 Myeloid leukaemia	0.012	0.988	0.000
C83.3 Large cell (diffuse)	0.012	0.988	0.000
C91.1 Chronic lymphocytic leukaemia	0.012	0.988	0.000
C90.0 Multiple myeloma	0.012	0.988	0.000
C95 Leukaemia of unspecified cell type	0.011	0.988	0.000
C86 Other specified types of T/NK-cell lymphoma	0.011	0.989	0.000
C81.1 Nodular sclerosis	0.011	0.989	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.011	0.989	0.000
C85.0 Lymphosarcoma	0.011	0.989	0.000
C93 Monocytic leukaemia	0.011	0.989	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.011	0.989	0.000
C81.3 Lymphocytic depletion	0.011	0.989	0.000
C81.2 Mixed cellularity	0.011	0.989	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.011	0.989	0.000
C94 Other leukaemias of specified cell type	0.011	0.989	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.011	0.989	0.000
C92.4 Acute promyelocytic leukaemia	0.010	0.990	0.000
C83.0 Small cell (diffuse)	0.010	0.990	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.010	0.990	0.000
C92.7 Other myeloid leukaemia	0.010	0.990	0.000
C90.3 Solitary plasmacytoma	0.009	0.990	0.000
C90.2 Plasmacytoma, extramedullary	0.009	0.990	0.000
C90.1 Plasma cell leukaemia	0.009	0.990	0.000
C83.6 Undifferentiated (diffuse)	0.009	0.991	0.000
C83.5 Lymphoblastic (diffuse)	0.009	0.991	0.000
C83.4 Immunoblastic (diffuse)	0.009	0.991	0.000
C83.2 Mixed small and large cell (diffuse)	0.009	0.991	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.009	0.991	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.991	0.009
K75 Other inflammatory liver diseases	0.000	0.991	0.009
C88 Malignant immunoproliferative diseases	0.009	0.991	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.009	0.991	0.000
C91.7 Other lymphoid leukaemia	0.009	0.991	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.009	0.991	0.000
C91.5 Adult T-cell leukaemia	0.009	0.991	0.000
C91.3 Prolymphocytic leukaemia	0.009	0.991	0.000
C91.2 Subacute lymphocytic leukaemia	0.009	0.991	0.000
K75.4 Autoimmune hepatitis	0.000	0.991	0.009
C95.9 Leukaemia, unspecified	0.009	0.991	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.009	0.991	0.000
C92.9 Myeloid leukaemia, unspecified	0.009	0.991	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.009	0.991	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.009	0.991	0.000
C92.5 Acute myelomonocytic leukaemia	0.009	0.991	0.000
C92.3 Myeloid sarcoma	0.009	0.991	0.000
C92.2 Subacute myeloid leukaemia	0.009	0.991	0.000
C83.7 Burkitt's tumour	0.009	0.991	0.000
C92.1 Chronic myeloid leukaemia	0.009	0.991	0.000
K75.0 Abscess of liver	0.000	0.991	0.009
C93.1 Chronic monocytic leukaemia	0.009	0.991	0.000
C91.0 Acute lymphoblastic leukaemia	0.008	0.991	0.000
C95.7 Other leukaemia of unspecified cell type	0.008	0.991	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.008	0.991	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.008	0.991	0.000
C95.0 Acute leukaemia of unspecified cell type	0.008	0.991	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.008	0.991	0.000
C86.4 Blastic NK-cell lymphoma	0.008	0.991	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.008	0.991	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.008	0.991	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.008	0.991	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.008	0.991	0.000
C93.9 Monocytic leukaemia, unspecified	0.008	0.992	0.000
C93.7 Other monocytic leukaemia	0.008	0.992	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.008	0.992	0.000
C93.2 Subacute monocytic leukaemia	0.008	0.992	0.000
C93.0 Acute monocytic leukaemia	0.008	0.992	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.008	0.992	0.000
C91.9 Lymphoid leukaemia, unspecified	0.008	0.992	0.000
C84.5 Other and unspecified T-cell lymphomas	0.008	0.992	0.000
K75.8 Other specified inflammatory liver diseases	0.000	0.992	0.008
C94.7 Other specified leukaemias	0.008	0.992	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.008	0.992	0.000
C94.5 Acute myelofibrosis	0.008	0.992	0.000
C94.4 Acute panmyelosis	0.008	0.992	0.000
C94.3 Mast cell leukaemia	0.008	0.992	0.000
C94.2 Acute megakaryoblastic leukaemia	0.008	0.992	0.000
C94.1 Chronic erythraemia	0.008	0.992	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.008	0.992	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.008	0.992	0.000
C96.8 Histiocytic sarcoma	0.008	0.992	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.008	0.992	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.008	0.992	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.008	0.992	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.008	0.992	0.000
C96.3 True histiocytic lymphoma	0.008	0.992	0.000
C96.2 Malignant mast cell tumour	0.008	0.992	0.000
C96.1 Malignant histiocytosis	0.008	0.992	0.000
C96.0 Letterer-Siwe disease	0.008	0.992	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.008	0.992	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.008	0.992	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.008	0.992	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.008	0.992	0.000
C84.3 Lymphoepithelioid lymphoma	0.008	0.992	0.000
C84.2 T-zone lymphoma	0.008	0.992	0.000
C84.1 Sezary's diease	0.008	0.992	0.000
C84.0 Mycosis fungoides	0.008	0.992	0.000
C91.4 Hairy-cell leukaemia	0.008	0.992	0.000
C84.4 Peripheral T-cell lymphoma	0.008	0.992	0.000
C92.0 Acute myeloid leukaemia	0.007	0.993	0.000
Z74.0 Reduced mobility	0.007	0.993	0.000
C83.1 Small cleaved cell (diffuse)	0.007	0.993	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.993	0.007
K75.2 Nonspecific reactive hepatitis	0.000	0.993	0.007
K75.1 Phlebitis of portal vein	0.000	0.993	0.007
S89.9 Unspecified injury of lower leg	0.000	0.993	0.007
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.007	0.993	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.007	0.993	0.000
C88.7 Other malignant immunoproliferative diseases	0.007	0.993	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.007	0.993	0.000
C88.3 Immunoproliferative small intestinal disease	0.007	0.993	0.000
C88.2 Gamma heavy chain disease	0.007	0.993	0.000
C88.1 Alpha heavy chain disease	0.007	0.993	0.000
Y57.9 Drug or medicament, unspecified	0.007	0.993	0.000
J00 Acute nasopharyngitis [common cold]	0.000	0.993	0.007
Q66.8 Other congenital deformities of feet	0.006	0.994	0.000
Q66 Congenital deformities of feet	0.006	0.994	0.000
Y57 Other and unspecified drugs and medicaments	0.006	0.994	0.000
Z74 Problems related to care-provider dependency	0.006	0.994	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.006	0.994	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.006	0.994	0.000
Q66.7 Pes cavus	0.006	0.994	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
Z74.1 Need for assistance with personal care	0.006	0.994	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
Q66.3 Other congenital varus deformities of feet	0.006	0.994	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
Y57.5 X-ray contrast media	0.005	0.994	0.000
C82.2 Large cell, follicular	0.005	0.994	0.000
M86.9 Osteomyelitis, unspecified	0.005	0.994	0.000
C82.0 Small cleaved cell, follicular	0.005	0.995	0.000
Y49.5 Other antipsychotics and neuroleptics	0.005	0.995	0.000
N41 Inflammatory diseases of prostate	0.000	0.995	0.005
W19.9 Unspecified place	0.000	0.995	0.005
C82.6 Cutaneous follicle centre lymphoma	0.005	0.995	0.000
C82.5 Diffuse follicle centre lymphoma	0.005	0.995	0.000
C82.4 Follicular lymphoma grade IIIb	0.005	0.995	0.000
C82.3 Follicular lymphoma grade IIIa	0.005	0.995	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Z74.2 Need for assistance at home and no other household member able to render care	0.005	0.995	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.005	0.995	0.000
Y53.4 Other laxatives	0.005	0.995	0.000
Z74.8 Other problems related to care-provider dependency	0.005	0.995	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
Z74.9 Problem related to care-provider dependency, unspecified	0.005	0.995	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.005	0.995	0.000
Y52 Agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y58 Bacterial vaccines	0.005	0.995	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.995	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
Q83 Congenital malformations of breast	0.005	0.995	0.000
Q83.1 Accessory breast	0.005	0.995	0.000
Q66.9 Congenital deformity of feet, unspecified	0.005	0.995	0.000
Q66.6 Other congenital valgus deformities of feet	0.005	0.995	0.000
Q66.5 Congenital pes planus	0.005	0.995	0.000
Q66.4 Talipes calcaneovalgus	0.005	0.995	0.000
Q66.2 Metatarsus varus	0.005	0.995	0.000
Q66.1 Talipes calcaneovarus	0.005	0.995	0.000
Q66.0 Talipes equinovarus	0.005	0.995	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Y57.7 Vitamins, not elsewhere classified	0.005	0.995	0.000
Y57.6 Other diagnostic agents	0.005	0.995	0.000
Y57.4 Pharmaceutical excipients	0.005	0.995	0.000
Y57.3 Alcohol deterrents	0.005	0.995	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
Y57.1 Lipotropic drugs	0.005	0.995	0.000
Y57.0 Appetite depressants [anorectics]	0.005	0.995	0.000
Z74.3 Need for continuous supervision	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.005	0.995	0.000
N94.1 Dyspareunia	0.005	0.995	0.000
W50-W64 Exposure to animate mechanical forces	0.005	0.995	0.000
Y41.5 Antiviral drugs	0.005	0.995	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.005	0.995	0.000
Chapter XX External causes of morbidity and mortality	0.005	0.995	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.005	0.995	0.000
Y59 Other and unspecified vaccines and biological substances	0.005	0.995	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.005	0.995	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.005	0.995	0.000
Q80-Q89 Other congenital malformations	0.005	0.995	0.000
Y42.2 Antithyroid drugs	0.005	0.995	0.000
D25.2 Subserosal leiomyoma of uterus	0.000	0.995	0.005
M86.94 Osteomyelitis, unspecified (Hand)	0.004	0.995	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.005	0.995	0.000
M86 Osteomyelitis	0.005	0.995	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
S89 Other and unspecified injuries of lower leg	0.000	0.995	0.005
Y49.9 Psychotropic drug, unspecified	0.004	0.995	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.004	0.995	0.000
Y49.7 Psychostimulants with abuse potential	0.004	0.995	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.004	0.995	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.995	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.995	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.995	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y53.7 Emetics	0.004	0.996	0.000
Y53.6 Antidiarrhoeal drugs	0.004	0.996	0.000
Y53.5 Digestants	0.004	0.996	0.000
Y53.3 Saline and osmotic laxatives	0.004	0.996	0.000
Y53.2 Stimulant laxatives	0.004	0.996	0.000
Y53.0 Histamine H2-receptor antagonists	0.004	0.996	0.000
D25.9 Leiomyoma of uterus, unspecified	0.000	0.996	0.004
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y00-Y09 Assault	0.004	0.996	0.000
Y42.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
Y42.4 Oral contraceptives	0.004	0.996	0.000
Y42.1 Thyroid hormones and substitutes	0.004	0.996	0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.004	0.996	0.000
Q83.8 Other congenital malformations of breast	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
Y41.0 Sulphonamides	0.004	0.996	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
Q85 Phakomatoses, not elsewhere classified	0.004	0.996	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.004	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
Z63.4 Disappearance and death of family member	0.004	0.996	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
Q61.3 Polycystic kidney, unspecified	0.004	0.996	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.004	0.996	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.004	0.996	0.000
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.004	0.996	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.004	0.996	0.000
M86.92 Osteomyelitis, unspecified (Upper arm)	0.004	0.996	0.000
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.004	0.996	0.000
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.004	0.996	0.000
D25 Leiomyoma of uterus	0.000	0.996	0.004
V01-V09 Pedestrian injured in transport accident	0.004	0.996	0.000
X49.9 Unspecified place	0.004	0.996	0.000
Y58.0 BCG vaccine	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
M86.6 Other chronic osteomyelitis	0.004	0.996	0.000
N41.8 Other inflammatory diseases of prostate	0.000	0.996	0.004
N41.3 Prostatocystitis	0.000	0.996	0.004
N41.2 Abscess of prostate	0.000	0.996	0.004
S89.8 Other specified injuries of lower leg	0.000	0.996	0.004
C82.1 Mixed small cleaved and large cell, follicular	0.004	0.996	0.000
Q61 Cystic kidney disease	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
Q61.2 Polycystic kidney, adult type	0.004	0.996	0.000
M89.8 Other specified disorders of bone	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
W75-W84 Other accidental threats to breathing	0.004	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
W55 Bitten or struck by other mammals	0.004	0.996	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.004	0.996	0.000
Y00 Assault by blunt object	0.004	0.996	0.000
Y52.1 Calcium-channel blockers	0.004	0.996	0.000
Q67 Congenital musculoskeletal deformities of head, face, spine and chest	0.004	0.996	0.000
M89.84 Other specified disorders of bone (Hand)	0.004	0.996	0.000
D25.0 Submucous leiomyoma of uterus	0.000	0.996	0.004
Q74 Other congenital malformations of limb(s)	0.004	0.996	0.000
X50-X57 Overexertion, travel and privation	0.004	0.996	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.004	0.996	0.000
Y57.8 Other drugs and medicaments	0.004	0.996	0.000
V90-V94 Water transport accidents	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Y10-Y34 Event of undetermined intent	0.004	0.996	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.004	0.996	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.004	0.996	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.004	0.996	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
X00-X09 Exposure to smoke, fire and flames	0.004	0.996	0.000
V95-V97 Air and space transport accidents	0.004	0.996	0.000
W50.9 Unspecified place	0.004	0.996	0.000
W60.0 Home	0.004	0.996	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
Y52.7 Peripheral vasodilators	0.004	0.996	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
W64 Exposure to other and unspecified animate mechanical forces	0.004	0.996	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
Y58.9 Other and unspecified bacterial vaccines	0.004	0.996	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.004	0.996	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.004	0.996	0.000
Y58.5 Diphtheria vaccine	0.004	0.996	0.000
Y58.4 Tetanus vaccine	0.004	0.996	0.000
Y58.3 Plague vaccine	0.004	0.996	0.000
Y58.2 Cholera vaccine	0.004	0.996	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.004	0.996	0.000
Q60-Q64 Congenital malformations of the urinary system	0.004	0.996	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.004	0.996	0.000
M86.66 Other chronic osteomyelitis (Lower leg)	0.004	0.996	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.004	0.996	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.004	0.996	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.004	0.996	0.000
V20-V29 Motorcycle rider injured in transport accident	0.004	0.996	0.000
M86.1 Other acute osteomyelitis	0.004	0.996	0.000
Q83.9 Congenital malformation of breast, unspecified	0.004	0.996	0.000
Q83.3 Accessory nipple	0.004	0.996	0.000
Q83.2 Absent nipple	0.004	0.996	0.000
Q83.0 Congenital absence of breast with absent nipple	0.004	0.996	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.996	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
V01 Pedestrian injured in collision with pedal cycle	0.004	0.996	0.000
W51 Striking against or bumped into by another person	0.004	0.996	0.000
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system	0.004	0.996	0.000
Y00.9 Unspecified place	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
Q82 Other congenital malformations of skin	0.004	0.996	0.000
Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine	0.004	0.996	0.000
Q75 Other congenital malformations of skull and face bones	0.004	0.996	0.000
Q73 Reduction defects of unspecified limb	0.004	0.996	0.000
Q72 Reduction defects of lower limb	0.004	0.996	0.000
Q71 Reduction defects of upper limb	0.004	0.996	0.000
Q70 Syndactyly	0.004	0.996	0.000
Q69 Polydactyly	0.004	0.996	0.000
Q68 Other congenital musculoskeletal deformities	0.004	0.996	0.000
W59 Bitten or crushed by other reptiles	0.004	0.996	0.000
W58 Bitten or struck by crocodile or alligator	0.004	0.996	0.000
W56 Contact with marine animal	0.004	0.996	0.000
W54 Bitten or struck by dog	0.004	0.996	0.000
W53 Bitten by rat	0.004	0.996	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.004	0.996	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.004	0.996	0.000
V40-V49 Car occupant injured in transport accident	0.004	0.996	0.000
Q85.9 Phakomatosis, unspecified	0.004	0.996	0.000
Q78 Other osteochondrodysplasias	0.004	0.996	0.000
Y04 Assault by bodily force	0.004	0.996	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.004	0.996	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.004	0.996	0.000
Y80 Physical medicine devices associated with adverse incidents	0.004	0.996	0.000
Y78 Radiological devices associated with adverse incidents	0.004	0.996	0.000
Y75 Neurological devices associated with adverse incidents	0.004	0.996	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.004	0.996	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.004	0.996	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.004	0.996	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.004	0.996	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.004	0.996	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.996	0.000
Z73.3 Stress, not elsewhere classified	0.004	0.996	0.000
W84 Unspecified threat to breathing	0.004	0.996	0.000
Y35-Y36 Legal intervention and operations of war	0.004	0.996	0.000
X85-X99 Assault	0.004	0.996	0.000
X30-X39 Exposure to forces of nature	0.004	0.996	0.000
W65-W74 Accidental drowning and submersion	0.004	0.996	0.000
V70-V79 Bus occupant injured in transport accident	0.004	0.996	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.004	0.996	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.996	0.000
Y47.4 Bromine compounds	0.003	0.996	0.000
Y47.3 Paraldehyde	0.003	0.996	0.000
Y47.2 Chloral derivatives	0.003	0.996	0.000
Y47.1 Benzodiazepines	0.003	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.996	0.000
Y50.8 Other central nervous system stimulants	0.003	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.996	0.000
Y50.1 Opioid receptor antagonists	0.003	0.996	0.000
Y50.0 Analeptics	0.003	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.996	0.000
Y55.5 Anticommon cold drugs	0.003	0.996	0.000
Y55.4 Expectorants	0.003	0.996	0.000
Y55.3 Antitussives	0.003	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.996	0.000
Y55.0 Oxytocic drugs	0.003	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.996	0.000
Y59.3 Immunoglobulin	0.003	0.996	0.000
Y59.2 Protozoal vaccines	0.003	0.996	0.000
Y59.1 Rickettsial vaccines	0.003	0.996	0.000
Y59.0 Viral vaccines	0.003	0.996	0.000
V80-V89 Other land transport accidents	0.004	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
Y76.8 Miscellaneous devices, not elsewhere classified	0.003	0.996	0.000
Y76.3 Surgical instruments, materials and devices (including sutures)	0.003	0.996	0.000
Y76.1 Therapeutic (nonsurgical) and rehabilitative devices	0.003	0.996	0.000
Y76.0 Diagnostic and monitoring devices	0.003	0.996	0.000
X10-X19 Contact with heat and hot substances	0.004	0.996	0.000
W55.7 Farm	0.003	0.996	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.003	0.996	0.000
Q84 Other congenital malformations of integument	0.003	0.996	0.000
Q81 Epidermolysis bullosa	0.003	0.996	0.000
Q80 Congenital ichthyosis	0.003	0.996	0.000
N41.0 Acute prostatitis	0.000	0.996	0.004
X49.6 Industrial and construction area	0.003	0.996	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.003	0.996	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.003	0.996	0.000
Q76 Congenital malformations of spine and bony thorax	0.003	0.996	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.003	0.996	0.000
M86.5 Other chronic haematogenous osteomyelitis	0.003	0.996	0.000
M86.4 Chronic osteomyelitis with draining sinus	0.003	0.996	0.000
M86.3 Chronic multifocal osteomyelitis	0.003	0.996	0.000
M86.2 Subacute osteomyelitis	0.003	0.996	0.000
M86.0 Acute haematogenous osteomyelitis	0.003	0.996	0.000
X48 Accidental poisoning by and exposure to pesticides	0.003	0.996	0.000
X46 Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.003	0.996	0.000
X45 Accidental poisoning by and exposure to alcohol	0.003	0.996	0.000
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.003	0.996	0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.003	0.996	0.000
X40 Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.003	0.996	0.000
M86.8 Other osteomyelitis	0.003	0.996	0.000
S89.7 Multiple injuries of lower leg	0.000	0.996	0.003
S89.1 Other specified injuries of lower leg	0.000	0.996	0.003
S89.0 Multiple injuries of lower leg	0.000	0.996	0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations